ASCO15: Spectrum Pharmaceuticals, Inc. Highlights Five Abstracts Of Clinical Data At The 2015 ASCO Annual Meeting In Chicago, Illinois, May 29-June 2, 2015

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced presentations of clinical data for Beleodaq® (belinostat), Folotyn® (pralatrexate injection) and Poziotinib to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, being held in Chicago, Illinois, from May 29 to June 2, 2015.

Help employers find you! Check out all the jobs and post your resume.